Posted by Michael Wonder on 08 Apr 2021
‘Before end of this year’: Novavax COVID vaccine could be months away
8 April 2021 - Regulatory approvals for the third pillar of Australia’s vaccine strategy may not be obtained until the end of the year, keeping the country largely reliant on the AstraZeneca jab for the time being.
Australia has more than 50 million doses of Novavax’s COVID vaccine on order, and while the US pharma giant is confident it can deliver, there is no set timeline in its contract.
The local rollout could be months away, with the company prioritising approvals from regulators in the US and the UK first.
